We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

EQUBITS Licenses Foresight to Novartis and Johnson and Johnson

Read time: Less than a minute

EQUBITS have announced the first customers of their flagship product, EQUBITS Foresight. Customers include Novartis, Johnson and Johnson PRD, and BASF.

"After extensive testing and validation, customers are purchasing EQUBITS Foresight as an easy-to-use software solution for their data mining problems. Our customers expect a lot from new software and, as a result, evaluated and tested Equbits Foresight rigorously. By outperforming existing methods in customer evaluations, EQUBITS has established itself as a best in class, accurate, interpretable predictive modeling solution provider," says Ravi Mallela, VP of Marketing, EQUBITS LLC.

EQUBITS Foresight is being used to solve complex predictive modeling problems in the High Throughput Screening and ADME-Tox environments.
By applying EQUBITS Foresight to challenging predictive modeling problems, customers are generating more accurate, interpretable results.

"Equbits provides customers with data mining solutions that combine the accuracy of non-linear modeling with a level of interpretability provided by linear models," says Dr. Mallela.